For March, the Global Light Vehicle (LV) selling rate is estimated to be 90 million units/year, an improvement on the ...

The top 20 biopharmas demonstrated a strong start to 2025, despite ongoing uncertainty surrounding Trump’s tariffs.

Merck KGaA has confirmed that it is in late-stage discussions with SpringWorks, valuing the deal at a price of around $47 per ...

Robust demand for battery electric vehicles so far in 2025 has eroded ICE volume and helped push diesel share to the lowest ...

A new report from GlobalData, a data and analytics group, projects global nuclear power capacity will hit 494 GW by 2035. The ...

President Trump’s latest tariff tweaks appear to have helped stabilize U.S. financial markets — at least, for now.

The fragmentation of the wind turbine supply chain poses an existential threat to global wind power expansion.

According to GlobalData, these tariffs are expected to impact all 510(k)-approved medical devices manufactured outside of the ...

China’s high-net-worth investors prioritised “safety” in 2024 amid a period of economic turbulence, according to a new report ...

Barclays has secured the top position as the leading financial adviser for mergers and acquisitions (M&A) during the first ...

Allen & Overy and Kirkland & Ellis have emerged as the top legal advisers for M&A during the first quarter of 2025 in the ...

The impact of long-acting injectables (LAIs) for HIV was discussed at the 35th ESCMID Global conference in Vienna, Austria.